Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants
Clinical trial NCT02568566 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02568566
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-19
- Primary completion
- 2020-02-06
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.